Pharmaceuticals

31 August 2021 by Konstanze Richter

Anaemia drug

Fibrogen and Carpmaels defend anaemia drug in UK appeal

Fibrogen has prevailed against competitor Akebia over six patents relating to a drug used in anaemia treatment. The UK Court of Appeal has declared se ...

20 August 2021 by Mathieu Klos

Veterinary medicine

Ceva escalates dispute with Bayer and Elanco over veterinary drug

Bayer and Elanco may not sell the veterinary drug BayCox Iron in injection form in Germany. In mid-July Düsseldorf Regional Court ruled the product in ...

df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB

Michael Eder

Michael Eder heads the firm’s chemistry practice group. Dr. Eder began his career in intellectual property in 1999 and joined df-mp in 2000. Since 2007, he is a partner in the ...

df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB

Elisabeth Greiner

Elisabeth Greiner joined df-mp in 2005 and is a member of the firm’s chemistry and pharmaceuticals practice groups. She is a partner in the firm since 2012 and has an in-depth ...

df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB

Sandra Pohlman

Sandra Pohlman is co-founder and partner of df-mp. She heads the firm’s large and diversified biotechnology and pharmaceuticals practice group together with Dr. Dörries. Ms. P ...

df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB

H. Ulrich Dörries

Ulrich Dörries has been active in intellectual property since 1993 and is co-founder and partner of df-mp. His technical expertise inter alia spans the areas molecular biology ...

19 July 2021 by Amy Sandys

France

Paris Court of Appeal confirms no preliminary injunction against Mylan

A Paris court has rejected Allergan's request for preliminary injunction measures against defendant Mylan over treatment for eye condition glaucoma. T ...

Simmons & Simmons LLP

Johan Renes

Johan has over 30 years of experience in life science, and is a partner in our Intellectual Property practice. Since his industry start in the late eighties he has been contin ...

1 July 2021 by Amy Sandys

Biosimilars

Polpharma and Wuesthoff succeed in revoking MS drug patent

The Opposition Division of the European Patent Office has revoked a Biogen patent, which covers treatment for multiple sclerosis. In May 2020, Polphar ...

8 June 2021 by Konstanze Richter

France

Bardehle Pagenberg bolsters Paris office with two patent attorneys

Bardehle Pagenberg has strengthened its Paris team with two patent attorneys, Lionel Vial and Margaux Esselin. Both specialise in life sciences, compl ...

7 June 2021 by Amy Sandys

The Netherlands

Pinsent Masons grows new Amsterdam office with life sciences partner

The new Amsterdam office of Pinsent Masons has welcomed Machteld Hiemstra, who joins from Simmons & Simmons, as its third partner. Hiemstra brings ...

August Debouzy

François Pochart

François Pochart joined August Debouzy in 2011, after having worked as a French and European patent attorney for more than 15 years. A graduate of Polytechnique, ENSIC, Paris ...

20 May 2021 by Amy Sandys

Second medical use

Alcon wins with Bristows over glaucoma drug patent validity

The UK High Court has upheld in revocation proceedings a patent owned by Alcon, which covers a drug used to treat the eye condition glaucoma. The deci ...

17 May 2021 by Christina Schulze

Interview

Christoph Ann: "Licensing relevant COVID-19 patents would increase their availability"

Christoph Ann, professor for Intellectual Property Law at TUM School of Management, explains the legal implications of waiving patent protection for C ...